KAYLA DELVALLE: Open Payments
NPI 1841748837 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 7 payments from 4 companies in 2025. Trend: 2023 $298 · 2024 $840 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 3 | $191 |
| Abbott Laboratories | 1 | $136 |
| Novo Nordisk Inc | 2 | $124 |
| Sequel Med Tech, LLC | 1 | $119 |
Products named: OMNIPOD, FREESTYLE LIBRE 3, Ozempic, TWIIST.
Industry payments across MA — which companies pay providers there.
